Translational Oncology

Published by: Elsevier Science, Inc.  

People

  1. Pillarsetty
    Pillarsetty
  2. Ackerstaff
    Ackerstaff
  3. Danila
    Danila
  4. De Stanchina
    De Stanchina
  5. Deasy
    Deasy
  6. Grewal
    Grewal
  7. Haimovitz-Friedman
    Haimovitz-Friedman
  8. Hajj
    Hajj
  9. Humm
    Humm
  10. Kalidindi
    Kalidindi

Groups

  1. Radiology, Department of (5)
  2. Sloan Kettering Institute Postdocs (4)
  3. Department of Medicine (3)
  4. Radiochemistry and Imaging Sciences Service (3)
  5. Surgery (3)
  6. GSK Faculty (2)
  7. Genitourinary Oncology Service (2)
  8. Medical Physics (2)
  9. Molecular Imaging and Therapy Service (2)
  10. Solid Tumor Oncology Division (2)
Search Within
Formats
  1. Journal Article (16)
  2. Review (1)
Groups
  1. Radiology, Department of (5)
  2. Sloan Kettering Institute Postdocs (4)
  3. Department of Medicine (3)
  4. Radiochemistry and Imaging Sciences Service (3)
  5. Surgery (3)
  6. GSK Faculty (2)

More Groups

People
  1. Binsheng Zhao (2)
  2. Eric Holland (2)
  3. Nagavarakishore Pillarsetty (2)
  4. Adriana Haimovitz-Friedman (1)
  5. Anas Younes (1)
  6. Andrew Simpson (1)

More People

Years
  1. 2023 (1)
  2. 2022 (2)
  3. 2021 (2)
  4. 2020 (2)
  5. 2017 (1)
  6. 2016 (1)

More Years

Publishers
  1. Elsevier Science, Inc. (17)

Results (17)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cyclotron vs generator-produced 68Ga PSMA: A single-institution, prospective clinical trial
    Journal Article

    Martinez, J.; Subramanian, K.; Castellanos, S. H.; Thomas, C.; Choudhury, A. R.; Muench, B.; Tagawa, S. T.; Pillarsetty, N. V. K.; Osborne, J. R.
    Translational Oncology (2023)

    Fulltext@MSK | Save
  • Assessment of salivary gland function after (177)Lu-PSMA radioligand therapy: Current concepts in imaging and management
    Review

    Mahajan, S.; Grewal, R. K.; Friedman, K. P.; Schöder, H.; Pandit-Taskar, N.
    Translational Oncology (2022)

    Fulltext@MSK | Save
  • Inhibitory monoclonal antibody targeting ADAM17 expressed on cancer cells
    Journal Article

    Saha, N.; Xu, K.; Zhu, Z.; Robev, D.; Kalidindi, T.; Xu, Y.; Himanen, J.; de Stanchina, E.; Pillarsetty, N. V. K.; Dimitrov, D. S.; more...
    Translational Oncology (2022)

    Fulltext@MSK | Save
  • Peripheral blood values as predictors of autoimmune status in oral cavity squamous cell carcinoma
    Journal Article

    Pillai, A.; Valero, C.; Navas, K.; Morris, Q.; Patel, S. G.
    Translational Oncology (2021)

    Fulltext@MSK | Save
  • Biomarkers of response to ibrutinib plus nivolumab in relapsed diffuse large B-cell lymphoma, follicular lymphoma, or Richter's transformation
    Journal Article

    Hodkinson, B. P.; Schaffer, M.; Brody, J. D.; Jurczak, W.; Carpio, C.; Ben-Yehuda, D.; Avivi, I.; Forslund, A.; Özcan, M.; Alvarez, J.; more...
    Translational Oncology (2021)

    Fulltext@MSK | Save
  • A combined FAK, c-MET, and MST1R three-protein panel risk-stratifies colorectal cancer patients
    Journal Article

    Yoon, J. Y.; Wang, J. Y.; Roehrl, M. H. A.
    Translational Oncology (2020)

    Fulltext@MSK | Save
  • B7–H3 as a prognostic biomarker and therapeutic target in pediatric central nervous system tumors
    Journal Article

    Maachani, U. B.; Tosi, U.; Pisapia, D. J.; Mukherjee, S.; Marnell, C. S.; Voronina, J.; Martinez, D.; Santi, M.; Dahmane, N.; Zhou, Z.; more...
    Translational Oncology (2020)

    Fulltext@MSK | Save
  • A combination of radiation and the hypoxia-activated prodrug evofosfamide (TH-302) is efficacious against a human orthotopic pancreatic tumor model
    Journal Article

    Hajj, C.; Russell, J.; Hart, C. P.; Goodman, K. A.; Lowery, M. A.; Haimovitz-Friedman, A.; Deasy, J. O.; Humm, J. L.
    Translational Oncology (2017)

    Fulltext@MSK | Save
  • miR-1207-3p is a novel prognostic biomarker of prostate cancer
    Journal Article

    Das, D. K.; Osborne, J. R.; Lin, H. Y.; Park, J. Y.; Ogunwobi, O. O.
    Translational Oncology (2016)

    Fulltext@MSK | Save
  • 18F-fluorodeoxyglucose uptake and tumor hypoxia: Revisit 18F-fluorodeoxyglucose in oncology application
    Journal Article

    Li, X. F.; Du, Y.; Ma, Y.; Postel, G. C.; Civelek, A. C.
    Translational Oncology (2014)

    Fulltext@MSK | Save

    • Translational Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Translational Oncology 1936-5233 Elsevier Science, Inc.
    Translational Oncology 19365233 Unknown
    Translational Oncology 1936-5233 Elsevier Science, Inc.
    Translational Oncology 1936-5233 Elsevier Science, Inc.
    Translational Oncology 1936-5233 Elsevier Science, Inc.
    Translational Oncology 1944-7124 Neoplasia Press, Inc
    Translational Oncology 19365233 2022
    Translational Oncology 1936-5233 Unknown
    Translational Oncology 19365233 Neoplasia Press, Inc
    Translational Oncology 1936-5233 Neoplasia Press, Inc
    Translational Oncology 19365233 Neoplasia Press, Inc
    Translational Oncology 1944-7124 Elsevier Science, Inc.
    Translational Oncology 19365233 The Authors
    Translational Oncology 1936-5233 The Authors
    Translational Oncology 1936-5233 Elsevier Inc.
    Translational Oncology 1944-7124 Elsevier Science, Inc.